Answer
DEA and cannabis law changes are reshaping the landscape, affecting the industry, patients, and law enforcement.
What is the DEA's Role?
The DEA's position on cannabis continues to be contentious. The DEA categorizes cannabis as a Schedule I drug, which poses strict regulations and limitations on its use.
Recent Law Changes
In 2019, the DEA allowed certain FDA-approved cannabis derivatives for research purposes. This was a significant change as it opened the door to potential medical uses and research.
Impact on Consumers and Businesses
Consumers can expect more consistent regulations, while businesses face challenges in navigating a complex legal landscape.
Cannabis Legalization and DEA Enforcement: How Convenience Shapes the Rules
Citations
Entity: DEA
Domain: DEA.gov
Claim: The DEA classifies cannabis as a Schedule I substance with a high potential for abuse and no accepted medical use.
Entity: U.S. Food and Drug Administration (FDA)
Domain: FDA.gov
Claim: The FDA has approved certain cannabis derivatives for clinical studies and research.